Sarcopenia in Colorectal Cancer Surgery-Minimally Invasive vs. Open.

ABSTRACT:

Background

Sarcopenia, characterized by loss of skeletal muscle mass and strength, is prevalent in patients undergoing treatment for colorectal cancer. Sarcopenia's prevalence in patients with cancer can reach up to 50% and is known to exacerbate postsurgical complications and affect long-term oncological outcomes. This study examined whether minimally invasive surgery (MIS) offers protective benefits against postoperative sarcopenia compared with open surgery in patients undergoing rectal cancer resection.

Methods

This retrospective analysis included 145 patients who underwent open or minimally invasive (laparoscopic or robot-assisted) rectal resections at the University Hospital Dresden between 2013 and 2021. Confounding variables were adjusted using propensity score match

SUBMITTER: Merboth F 

PROVIDER: S-EPMC12439183 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature